Interested in most meaningful advantages that influence docs to buy into Eliquis and how to leverage versus Savaysa - thoughts?
thoughts? Here's a thought for you, what the hell kind of nit-wits are these consultant companies hiring? Geesh, we are all aware they peruse CP to rip-off messaging and market info. But do you really think we are that foolish to just spill and fill in the blanks so that moron OP can easily cash in and try to look like a genius to their peers, boss, and clients? Running out of luck nim-wit.
Just read their PI once a day we all know how compliance drops with bid. Safety efficacy and study all look pretty good. Not feeling as confidant now
Are you kidding? NOTHING is UNKNOWN in a world of pharma theft. I'll give you ..3....E reasons: 1) D ..... 2) T.....3) C..... Prices for 180 tablets of Eliquis 5mg (brand) $962.00 times 4 = $3,848 a year. Warfarin is $4 per 30 * 12 = $48 plus INRs and travel to be monitored. Lets say, $380 a year. Ten fold the cost...for ten fold the effacacy and safety VS a well controlled anticoag. service? No, but this is AMERICA. Land of the American patient, land of the "Buy 'em Off" from government officials to BPMs to virtuous academic clinicians. So, WOW, $1.2 to $1.5B, for 2015 shared 50/50 with PFE, not a bad pay day, boys and girls! But the kicker is, as usage grows, there will be BAD news on the SE front this year. SEs can no longer be placed in a bottom drawer. Risk is everywhere. And if, well controlled warfarin can see litigation; so will over stated, real world SAFETY of apixiban BID. Even a reversal agent doesn't solve what is 'unmonitored' in real patients. (No financial interests in ANY newer or old OAC.)
Written by someone whose never had to deal with beinf on warfarin, has had a loved one die from bleeding in the brain, and someone who thinks 1 pill is for everyone.
